Viewing Study NCT03017833


Ignite Creation Date: 2025-12-25 @ 2:53 AM
Ignite Modification Date: 2026-02-27 @ 11:19 AM
Study NCT ID: NCT03017833
Status: COMPLETED
Last Update Posted: 2023-10-04
First Post: 2017-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory Cancers
Sponsor: M.D. Anderson Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2014-0186
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View